alvesco 160 inhaler
covis pharma gmbh - ciclesonide - pressurised inhalation - 160microgram/1dose
alvesco 160 inhaler
waymade healthcare plc - ciclesonide - pressurised inhalation - 160microgram/1dose
controloc
takeda gmbh - pantoprazole (pantoprazole sodium sesquihydrate) - tablets gastro-resistant - 40mg
controloc
takeda gmbh - pantoprazole (pantoprazole sodium sesquihydrate) - powder for solution for injection - 40mg
controloc
takeda gmbh - pantoprazole (pantoprazole sodium sesquihydrate) - tablets gastro-resistant - 20mg
alvesco 160 micrograms pressurised inhalation, solution
astrazeneca ab - ciclesonide - pressurised inhalation, solution - 160 microgram(s) - glucocorticoids; ciclesonide
alvesco 80 micrograms pressurised inhalation, solution
astrazeneca ab - ciclesonide - pressurised inhalation, solution - 80 microgram(s) - glucocorticoids; ciclesonide
alvesco 160 inhaler
cst pharma ltd - ciclesonide - pressurised inhalation - 160microgram/1dose
dexilant 30 mg
takeda israel ltd - dexlansoprazole - modified release capsules - dexlansoprazole 30 mg - dexlansoprazole - dexilant 30 is indicated in adults and in adolescents aged 12 to 17 years for the following:• maintenance of healed erosive reflux oesophagitis and maintenance of relief of heartburn• short-term treatment of heartburn and acid regurgitation associated with symptomatic non-erosive gastro-oesophageal reflux disease (gord).
dexilant 60 mg
takeda israel ltd - dexlansoprazole - modified release capsules - dexlansoprazole 60 mg - dexlansoprazole - dexilant 60 is indicated in adults and in adolescents aged 12 to 17 years for the following:• treatment of erosive reflux oesophagitis